Shackleton’s 24th Profitable Exit

We are pleased to announce that we have sold our interest in OmPrompt to Eurazeo-backed Elemica International, Inc.  OmPrompt is a leading developer of AI-based SaaS systems for processing order entries for consumer goods and healthcare companies. We originally acquired a significant interest in OmPrompt in December 2008 when we bought out equity investors and bank debt after OmPrompt’s momentum slowed in the global downturn.  [...]

2021-03-26T17:29:06+00:00March 26th, 2021|Categories: Exit, News, Press Release|Tags: , , |

Celebrating Return Fund #5’s first investment: Mentor Group

We are really pleased to announce that Return Fund #5 has made its first investment: Mentor Group. Our first transaction for the new Fund is a £2m initial secondary investment with a further primary tranche to follow later this year in Mentor Group, a leading supplier of sales transformation services and technology. Mentor enables customers to drive measurable and sustainable improvements in the performance of their salespeople [...]

2021-03-15T11:03:34+00:00March 12th, 2021|Categories: Acquisition, News, Press Release|Tags: , , , |

Return Fund #5

Shackleton Ventures, the specialist direct secondaries venture investor, has launched its fifth fund, the Shackleton Ruffena Return #5 Limited Partnership,  “Return Fund #5”, and will continue its proven strategy of investing in secondaries-led transactions that has resulted in each of its first four funds achieving top quartile performance. The fund is a collaboration between Shackleton and Ruffena Capital – a tie-up that substantially strengthens the [...]

2021-03-15T11:00:15+00:00March 7th, 2021|Categories: Funding, News, Press Release|Tags: , , , |

Investment Hat Trick

We are delighted to share this recent news from FinLeap's CEO Ramin Niroumand. The fintech sphere has been quite dynamic in recent weeks. The developments in the Wirecard case continue to dominate international news as the story gradually unfolds. However, there is also positive fintech news to share. Despite the summer break, many companies are working on their comebacks following the Corona crisis. The finleap [...]

2020-07-09T15:53:57+00:00July 8th, 2020|Categories: Funding, News|Tags: , , , , |

Hibergene’s game changing COVID test

Hibergene's newly CE-marked COVID-19 test delivers positive results in approximately 30 minutes and is now available for sale in Ireland and internationally. CE-approval followed the completion of a clinical evaluation study at the Mater Private Hospital, Dublin, Ireland, that has demonstrated the efficacy of the product. The new COVID-19 test, which expands the company’s product range to 13 tests, employs HiberGene’s proprietary molecular reagent format [...]

2020-07-31T13:53:47+00:00May 20th, 2020|Categories: News, Press Release|Tags: , |

NHS Louisa Jordan now Operational

We are pleased to report that NHS Louisa Jordan, built at the Scottish Event Campus is now operational. The hospital, which it is hoped will never be used, comprises 23,000 square metres of flooring more than 1,000 bed bays more than 8,000 pieces of medical equipment 35,000 metres of network cabling for the nurse call system 135,000 metres of cabling for lighting and power sockets [...]

2020-04-22T08:34:36+00:00April 22nd, 2020|Categories: News|Tags: , |

Shackleton Companies win Coveted Queen’s Awards

We are delighted to announce that 2 Shackleton companies have won Queen's Awards this year: Exterity and Trutac. The Queen’s Awards for Enterprise are the most prestigious awards for UK business.  With only 216 winners in 2020, the awards are designed to recognise and encourage truly outstanding achievements in innovation, export, sustainability, and promotion of social mobility.  Exterity won an accolade for its contribution to [...]

2020-04-22T07:51:38+00:00April 21st, 2020|Categories: Awards, News|Tags: , , |

Shackleton Team Invests in Hibergene

We are pleased to announce that the Shackleton team has invested in Hibergene Diagnostics.   The company develops, manufactures and markets molecular diagnostic tests for human infectious diseases, using LAMP (Loop Mediated Isothermal Amplification) technology. HiberGene is developing its next generation devices to disrupt the established time-consuming and high skilled testing market.  Its devices offer: Testing at front line medical centres; Real-time, accurate results within [...]

2020-04-22T07:44:18+00:00April 16th, 2020|Categories: Funding, News, Uncategorized|Tags: , , |

Scottish Event Campus to become temporary hospital

The Shackleton team has been working with its portfolio companies as they face the consequences of COVID-19.  While most companies are concentrating on measures to protect staff and deal with lockdown, one of our companies may have a more direct role.  The Scottish Event Campus could be in operation as a temporary hospital within two weeks. The new field hospital will be run by the [...]

2020-03-30T16:47:39+00:00March 30th, 2020|Categories: News|Tags: , |

Trutac: Shackleton’s 23rd Profitable Exit

We are pleased today to announce the sale of Trutac to Microlise.  The transaction sees the Coventry-based experts in fleet compliance and management software becoming a part of the Microlise group, which itself offers a broad range of fleet solutions including vehicle tracking, telematics and journey management. This is Shackleton’s 23rd profitable exit, delivering an IRR of 23%. Since our initial investment in 2010, Trutac has [...]

2020-03-09T18:53:16+00:00March 9th, 2020|Categories: Acquisition, News, Press Release|Tags: , |
Go to Top